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Avaliação quantitativa da intensidade da transpiração palmar e plantar  
em pacientes portadores de hiperidrose palmoplantar primária
Bruno Yoshihiro Parlato Sakiyama, Thaís Vera Monteiro, Augusto Ishy,  
José Ribas Milanez de Campos, Paulo Kauffman, Nelson Wolosker
Abstract
Objective: To compare individuals with and without hyperhidrosis in terms of the intensity of palmar and 
plantar sweating. Methods: We selected 50 patients clinically diagnosed with palmoplantar hyperhidrosis and 
25 normal individuals as controls. We quantified sweating using a portable noninvasive electronic device that 
has relative humidity and temperature sensors to measure transepidermal water loss. All of the individuals had a 
body mass index of 20-25 kg/cm2. Subjects remained at rest for 20-30 min before the measurements in order to 
reduce external interference. The measurements were carried out in a climate-controlled environment (21-24°C). 
Measurements were carried out on the hypothenar region on both hands and on the medial plantar region on 
both feet. Results: In the palmoplantar hyperhidrosis group, the mean transepidermal water loss on the hands 
and feet was 133.6 ± 51.0 g/m2/h and 71.8 ± 40.3 g/m2/h, respectively, compared with 37.9 ± 18.4 g/m2/h and 
27.6 ± 14.3 g/m2/h, respectively, in the control group. The differences between the groups were statistically 
significant (p < 0.001 for hands and feet). Conclusions: This method proved to be an accurate and reliable tool 
to quantify palmar and plantar sweating when performed by a trained and qualified professional.
Keywords: Hyperhidrosis; Sweat; Dermatology/instrumentation.
Resumo
Objetivo: Comparar a intensidade de transpiração em palmas das mãos e planta dos pés de indivíduos portadores 
de hiperidrose com a de um grupo controle. Métodos: Foram selecionados 50 pacientes com diagnóstico clínico 
de hiperidrose palmoplantar e 25 indivíduos controles. Um método objetivo de quantificação da transpiração foi 
utilizado com um aparelho eletrônico portátil, não invasivo, com sensores de umidade relativa e de temperatura 
capazes de quantificar a perda de água transepidérmica. Todos os indivíduos apresentavam índice de massa corpórea 
de 20-25 kg/cm2 e permaneceram em repouso por 20-30 min antes das medições para reduzir a interferência 
externa. A mensuração foi realizada em sala climatizada com a temperatura de 21-24°C. Os locais determinados 
para a aferição foram região hipotenar da face palmar e região medial da face plantar. Resultados: No grupo com 
hiperidrose palmoplantar, as médias da intensidade de transpiração nas mãos e nos pés foram de, respectivamente, 
133,6 ± 51,0 g/m2/h e 71,8 ± 40,3 g/m2/h, enquanto, no grupo controle, essas foram de 37,9 ±18,4 g/m2/h e 
27,6 ± 14,3 g /m2/h. As diferenças das médias entre os grupos foram estatisticamente significativas (p < 0,001). 
Conclusões: Este método de quantificação mostrou-se uma ferramenta precisa e confiável na avaliação da 
transpiração palmar e plantar, quando operado por um profissional treinado e capacitado.
Descritores: Hiperidrose; Suor; Dermatologia/instrumentação.
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sweating, as measured by the abovementioned 
portable device.
Methods
Between February and May of 2011, 
we measured the intensity of sweating in 
50 patients clinically diagnosed with palmoplantar 
hyperhidrosis (study group) and 25 individuals 
without hyperhidrosis (control group) by using 
the abovementioned portable device. The study 
was conducted in accordance with the guidelines 
of the local human research ethics committee. 
None of the patients had hyperhidrosis on other 
areas of the body. All of the patients had a body 
mass index of 20-25 kg/cm2.
We measured palmoplantar sweating 
with the abovementioned device, which is a 
portable noninvasive instrument that has a 
closed measurement chamber that eliminates 
any interference from drafts (air conditioning 
and breathing, as well as the opening and 
closing of doors and windows), allowing accurate 
measurement of transepidermal water loss. 
The chamber contains relative humidity and 
temperature sensors. For the measurements, 
the device was positioned perpendicular to the 
skin, remaining in contact with the skin surface 
until signaling that the reading was finished. The 
evaporation rate was automatically calculated by 
the device on the basis of an increase in relative 
humidity in the closed chamber. This measurement 
expresses the increase in water mass (in g) in 
relation to the area of evaporation (in m2) per 
unit of time (in h), the unit of measurement 
being therefore g/m2/h.
In order to standardize the quantification 
of sweating, all of the patients remained at 
rest for 20-30 min before the measurements 
in order to reduce external interference. The 
measurements were carried out in a climate-
controlled environment (21-24°C) at the 
hyperhidrosis outpatient clinic of the institution. 
Measurements were carried out on the hypothenar 
region on both hands (Figure 1) and on the 
medial plantar region on both feet (Figure 2).
We compared individuals with and without 
hyperhidrosis in terms of the intensity of palmar 
and plantar sweating.
In the statistical analysis, we evaluated the 
mean transepidermal water loss on the hands and 
feet for each group of patients, the intensity of 
palmoplantar sweating having been measured 
Introduction
Hyperhidrosis is a disorder characterized 
by excessive sweating (i.e., beyond what is 
physiologically necessary), especially on the palms, 
the axillae, the soles, and the face.(1,2) The etiology 
of hyperhidrosis is unknown and is associated 
with severe emotional, occupational, and social 
stress.(3) Hyperhidrosis begins in childhood or 
adolescence(4) and leads to significant loss of 
quality of life.(5) Between 12.5% and 56.5% of 
all patients with hyperhidrosis have a family 
history of the disease.(6)
The treatment of hyperhidrosis aims at 
reducing sweating on the regions where there 
is sweat hypersecretion. Among clinical treatments 
are anticholinergic drugs—which inhibit the 
sympathetic impulses and whose side effects 
include dry mouth, visual disorders, urinary 
retention, constipation, and difficulty in chewing 
and swallowing(7)—and dermatological treatments, 
including application of astringent solutions or 
creams,(8) iontophoresis(9) (electrical saltwater baths 
applied to the affected area), which can reduce 
sweating on specific areas for a short period, 
and subcutaneous injection of botulinum toxin.
(10) In contrast, surgical treatment is definitive 
and consists of bilateral thoracic sympathectomy 
by video-assisted thoracoscopy, in which there 
is resection, thermal cauterization, or clipping 
of the sympathetic chain that is responsible for 
activating sweat glands in the region where one 
wants to eliminate profuse sweating.(11,12) The 
major side effect of the procedure is compensatory 
hyperhidrosis.(13,14) Most studies investigating the 
intensity or progression of hyperhidrosis after 
the different types of treatment are based on 
subjective assessment, meaning that they depend 
entirely on patient-reported data.(15) However, 
tests have been developed in order to measure 
the intensity of sweating in an objective manner. 
The Delfin VapoMeter (Delfin Technologies Ltd., 
Kuopio, Finland), a portable device that can 
measure water vapor loss through the skin, has 
recently been used in order to evaluate the results 
of treating primary hyperhidrosis.(16,17) In Brazil, 
reference values for palmoplantar sweating (based 
on objective measurements of sweating) have 
yet to be established.
The objective of the present study was to 
compare individuals with and without hyperhidrosis 
in terms of the intensity of palmar and plantar 
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with the Mann-Whitney U test. For all inferential 
analyses, the probability of a type I (α) error 
was set at 0.05.
Results
The results of the quantification of 
palmoplantar sweating in the palmoplantar 
hyperhidrosis group and in the control group are 
shown in Table 1. In the palmoplantar hyperhidrosis 
group, the mean transepidermal water loss on 
the hands and feet was 133.6 ± 51.0 g/m2/h and 
71.8 ± 40.3 g/m2/h, respectively, compared with 
37.9 ± 18.4 g/m2/h and 27.6 ± 14.3 g/m2/h, 
respectively, in the control group.
The mean values were higher in the 
palmoplantar hyperhidrosis group than in the 
control group, the differences between the groups 
being statistically significant (p < 0.001).
Discussion
The quantification of sweating plays an 
extremely important role in the evaluation of 
treatments for hyperhidrosis and other diseases 
in which transepidermal water loss on areas such 
as the face, the hands, the feet, the trunk, and 
the back might be altered, as is the case of carpal 
tunnel syndrome(18) and diabetes.(19)
Currently, quality-of-life questionnaires and 
indicators of patient satisfaction are often used 
for measuring the intensity of hyperhidrosis. On 
the basis of such reports, various attempts have 
been made to modify the extent of resection of 
sympathetic ganglia in thoracic sympathectomy 
in order to eliminate or reduce compensatory 
hyperhidrosis. However, the information thus 
obtained is subjective and varies from patient to 
patient, including symptom duration, symptom 
severity, extent and distribution of the sites of 
sweating, previous interventions, and postoperative 
results.(20-22)
Figure 1 - Measurement of the intensity of palmar 
sweating.
Figure 2 - Measurement of the intensity of plantar 
sweating.
Table 1 - Transepidermal water loss on the hands and feet in the hyperhidrosis and control groups.a
Variable
Group
p*
Hyperhidrosis Control
(n = 50) (n = 25)
Mean ± SD Median Range Mean ± SD Median Range
Transepidermal water loss 
on the hands, g/m2/h
133.6 ± 51.0 129.0 55.6-256.0 37.9 ± 18.4 29.6 19.1-83.2 < 0.001
Transepidermal water loss 
on the feet, g/m2/h
71.8 ± 40.3 62.3 18.4-228.0 27.6 ± 14.3 26.0 10.6-82.5 < 0.001
aFor each individual, measurements were performed on both hands and on both feet. *Mann-Whitney U test.
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The quantitative sweat measurement system 
(Q-sweat, model 1.0; WR Medical Electronics Co., 
Stillwater, MN, USA) was developed to measure 
transepidermal water loss on small skin surfaces 
in humans. Rand et al.(24) used it in order to assess 
the sweat response during electrical stimulation 
in patients with diabetes.
More recently, a device known as VapoMeter 
(Delfin Technologies Ltd.) was used in order 
to evaluate the results of sympathectomy by 
video-assisted thoracoscopy in the treatment of 
primary palmar and plantar hyperhidrosis.(15,16) 
The use of this device has been validated by 
De Paepe et al.,(25) who demonstrated that the 
measurements obtained by the device are more 
accurate and reliable than are those obtained by 
an open chamber device known as the Tewameter 
(Courage & Khazaka, Cologne, Germany), which 
is regarded as the reference standard.
To date, there have been no studies specifically 
focusing on measuring baseline sweating in 
hyperhidrosis patients or healthy individuals.
By using a portable device, we measured sweat 
rates in 50 hyperhidrosis patients and 25 healthy 
individuals and found that the former had much 
higher rates, the differences being statistically 
significant. We now have baseline data on the 
sweating response in normal individuals and in 
hyperhidrosis patients. These data can be used 
as a reference by professionals who might be 
interested in using the device in the evaluation 
of patients with hyperhidrosis.
Transepidermal water loss as measured by the 
device under study proved to be a very rapid, 
practical, and reliable technique for quantifying 
palmoplantar sweating when performed by a 
trained and qualified professional. Therefore, 
the technique can be used in medical practice 
and can be an ancillary test in the diagnosis of 
hyperhidrosis and in the assessment of disease 
severity.
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